Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Intestinal mucus-derived nanoparticle-mediated activation of Wnt/β-catenin signaling plays a role in induction of liver natural killer T cell anergy in mice.

Deng ZB, Zhuang X, Ju S, Xiang X, Mu J, Wang Q, Jiang H, Zhang L, Kronenberg M, Yan J, Miller D, Zhang HG.

Hepatology. 2013 Mar;57(3):1250-61. doi: 10.1002/hep.26086. Epub 2013 Feb 11.

PMID:
22991247
[PubMed - indexed for MEDLINE]
2.

Exosome-like nanoparticles from intestinal mucosal cells carry prostaglandin E2 and suppress activation of liver NKT cells.

Deng ZB, Zhuang X, Ju S, Xiang X, Mu J, Liu Y, Jiang H, Zhang L, Mobley J, McClain C, Feng W, Grizzle W, Yan J, Miller D, Kronenberg M, Zhang HG.

J Immunol. 2013 Apr 1;190(7):3579-89. doi: 10.4049/jimmunol.1203170. Epub 2013 Mar 6.

PMID:
23467936
[PubMed - indexed for MEDLINE]
Free Article
3.

Glycolipid antigen induces long-term natural killer T cell anergy in mice.

Parekh VV, Wilson MT, Olivares-Villagómez D, Singh AK, Wu L, Wang CR, Joyce S, Van Kaer L.

J Clin Invest. 2005 Sep;115(9):2572-83.

PMID:
16138194
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

α-Galactosylceramide but not phenyl-glycolipids induced NKT cell anergy and IL-33-mediated myeloid-derived suppressor cell accumulation via upregulation of egr2/3.

Huang JR, Tsai YC, Chang YJ, Wu JC, Hung JT, Lin KH, Wong CH, Yu AL.

J Immunol. 2014 Feb 15;192(4):1972-81. doi: 10.4049/jimmunol.1302623. Epub 2014 Jan 24.

PMID:
24465013
[PubMed - indexed for MEDLINE]
5.

Stimulation of a shorter duration in the state of anergy by an invariant natural killer T cell agonist enhances its efficiency of protection from type 1 diabetes.

Tohn R, Blumenfeld H, Haeryfar SM, Veerapen N, Besra GS, Porcelli SA, Delovitch TL.

Clin Exp Immunol. 2011 Apr;164(1):26-41. doi: 10.1111/j.1365-2249.2011.04323.x. Epub 2011 Mar 1.

PMID:
21361909
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Nanoparticle formulated alpha-galactosylceramide activates NKT cells without inducing anergy.

Thapa P, Zhang G, Xia C, Gelbard A, Overwijk WW, Liu C, Hwu P, Chang DZ, Courtney A, Sastry JK, Wang PG, Li C, Zhou D.

Vaccine. 2009 May 26;27(25-26):3484-8. doi: 10.1016/j.vaccine.2009.01.047. Epub 2009 Feb 5.

PMID:
19200815
[PubMed - indexed for MEDLINE]
7.

[NKT cells in the liver environment interact with Wnt/β-catenin and promote the emergence of liver carcinoma].

Anson M, Viguier M, Perret C, Couty JP.

Med Sci (Paris). 2012 May;28(5):473-5. doi: 10.1051/medsci/2012285010. Epub 2012 May 30. French. No abstract available.

PMID:
22642999
[PubMed - indexed for MEDLINE]
Free Article
8.

The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells.

Kitamura H, Iwakabe K, Yahata T, Nishimura S, Ohta A, Ohmi Y, Sato M, Takeda K, Okumura K, Van Kaer L, Kawano T, Taniguchi M, Nishimura T.

J Exp Med. 1999 Apr 5;189(7):1121-8.

PMID:
10190903
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Activation or anergy: NKT cells are stunned by alpha-galactosylceramide.

Sullivan BA, Kronenberg M.

J Clin Invest. 2005 Sep;115(9):2328-9.

PMID:
16138189
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

WNT/β-catenin pathway is modulated in asthma patients and LPS-stimulated RAW264.7 macrophage cell line.

Lee H, Bae S, Choi BW, Yoon Y.

Immunopharmacol Immunotoxicol. 2012 Feb;34(1):56-65. doi: 10.3109/08923973.2011.574704. Epub 2011 Jun 24.

PMID:
21699440
[PubMed - indexed for MEDLINE]
11.

β-mannosylceramide activates type I natural killer t cells to induce tumor immunity without inducing long-term functional anergy.

O'Konek JJ, Kato S, Takao S, Izhak L, Xia Z, Illarionov P, Besra GS, Terabe M, Berzofsky JA.

Clin Cancer Res. 2013 Aug 15;19(16):4404-11. doi: 10.1158/1078-0432.CCR-12-2169. Epub 2013 Jun 26.

PMID:
23804426
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.

Sharif S, Arreaza GA, Zucker P, Mi QS, Sondhi J, Naidenko OV, Kronenberg M, Koezuka Y, Delovitch TL, Gombert JM, Leite-De-Moraes M, Gouarin C, Zhu R, Hameg A, Nakayama T, Taniguchi M, Lepault F, Lehuen A, Bach JF, Herbelin A.

Nat Med. 2001 Sep;7(9):1057-62.

PMID:
11533711
[PubMed - indexed for MEDLINE]
13.

Activation of the canonical WNT signaling pathway promotes ovarian surface epithelial proliferation without inducing β-catenin/Tcf-mediated reporter expression.

Usongo M, Li X, Farookhi R.

Dev Dyn. 2013 Mar;242(3):291-300. doi: 10.1002/dvdy.23919. Epub 2013 Feb 6.

PMID:
23239518
[PubMed - indexed for MEDLINE]
14.

The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes.

Nishimura T, Kitamura H, Iwakabe K, Yahata T, Ohta A, Sato M, Takeda K, Okumura K, Van Kaer L, Kawano T, Taniguchi M, Nakui M, Sekimoto M, Koda T.

Int Immunol. 2000 Jul;12(7):987-94.

PMID:
10882410
[PubMed - indexed for MEDLINE]
Free Article
15.

Inhibition by chondroitin sulfate E can specify functional Wnt/β-catenin signaling thresholds in NIH3T3 fibroblasts.

Willis CM, Klüppel M.

J Biol Chem. 2012 Oct 26;287(44):37042-56. doi: 10.1074/jbc.M112.391490. Epub 2012 Aug 22.

PMID:
22915582
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Recombinant Wnt3a and Wnt5a elicit macrophage cytokine production and tolerization to microbial stimulation via Toll-like receptor 4.

Yu CH, Nguyen TT, Irvine KM, Sweet MJ, Frazer IH, Blumenthal A.

Eur J Immunol. 2014 May;44(5):1480-90. doi: 10.1002/eji.201343959. Epub 2014 Mar 7.

PMID:
24643512
[PubMed - indexed for MEDLINE]
17.

Type II NKT cell-mediated anergy induction in type I NKT cells prevents inflammatory liver disease.

Halder RC, Aguilera C, Maricic I, Kumar V.

J Clin Invest. 2007 Aug;117(8):2302-12.

PMID:
17641782
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.

Fujii S, Shimizu K, Kronenberg M, Steinman RM.

Nat Immunol. 2002 Sep;3(9):867-74. Epub 2002 Aug 5.

PMID:
12154358
[PubMed - indexed for MEDLINE]
19.

Preactivation of NKT cells with alpha-GalCer protects against hepatic ischemia-reperfusion injury in mouse by a mechanism involving IL-13 and adenosine A2A receptor.

Cao Z, Yuan Y, Jeyabalan G, Du Q, Tsung A, Geller DA, Billiar TR.

Am J Physiol Gastrointest Liver Physiol. 2009 Aug;297(2):G249-58. doi: 10.1152/ajpgi.00041.2009. Epub 2009 Jun 25.

PMID:
19556359
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells.

Parekh VV, Lalani S, Kim S, Halder R, Azuma M, Yagita H, Kumar V, Wu L, Kaer LV.

J Immunol. 2009 Mar 1;182(5):2816-26. doi: 10.4049/jimmunol.0803648.

PMID:
19234176
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk